The correct and incorrect use of antibiotics: Prevalence survey in the Franche-Comté area;Bon et mauvais usage des antibiotiques enquête de: Prévalence en Franche-Comté

Presse Medicale

Volumn 31, Issue 33, 2002, Pages 1546-1550

  Floret, N ^a   Huc, B ^a   Mulin, B ^a   Talon, Daniel ^a  

^a UNIVERSITY HOSPITAL JEAN MINJOZ   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; CARBAPENEM; CEPHALOSPORIN; CEPHALOSPORIN DERIVATIVE; GENTAMICIN; GLYCOPEPTIDE; MACROLIDE; PENICILLIN DERIVATIVE; PENICILLIN G; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TOBRAMYCIN; UREIDOPENICILLIN;

ADULT; ANTIBIOTIC THERAPY; ARTICLE; ESCHERICHIA COLI; FRANCE; HOSPITAL INFECTION; HUMAN; INFECTION; MAJOR CLINICAL STUDY; PREVALENCE; PROPHYLAXIS; RISK ASSESSMENT; STATISTICAL ANALYSIS;

ANTI-BACTERIAL AGENTS; ANTIBIOTIC PROPHYLAXIS; COMMUNITY-ACQUIRED INFECTIONS; CROSS INFECTION; DRUG RESISTANCE; FRANCE; GUIDELINE ADHERENCE; HEALTH CARE SURVEYS; HOSPITALIZATION; HUMANS; PHYSICIAN'S PRACTICE PATTERNS; PREVALENCE;

EID: 0037069067     PISSN: 07554982     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Discours d'ouverture de M. Philippe Douste Blazy, Ministre délégué à la Santé. Journée "Infections nosocomiales" 3 novembre 1994, Paris. HygièneS 1994; 7: 15-20
2. re Ed. Paris: NHA, 1997
3. Gindre I, Maisonneuve H, Riche B, Durocher A. Le bon usage des antibiotiques à l'hôpital. État des lieux dans 207 établissements de santé publics et privés en 1999. Presse Med 2000; 29: 1807-12.
4. Gastmeier P, Bräuer H, Sohr D et al. Converting incidence and prevalence data of nosocomial infections: Results from eight hospitals. Infect Control Hosp Epidemiol 2001; 22: 31-4.
5. Société Française d'Anesthésie et de Réanimation. Recommandations pour la pratique de I'antibioprophylaxie en chirurgie: Actualisation 1999. La Lettre de I'lnfectiologue 1999; 40: 47-53.
6. Alfandari S, Bonenfant C, Depretere I, Beaucaire G et le réseau des Pharmaciens Hospitaliers de I'ARECLIN, Mise en place d'un observatoire régional de consommation des antibiotiques dans le Nord-Pas-de-Calais. BEH 2000; 14: 59-61.
7. Astagneau P, Fleury L, Leroy S et al. Cost of antimicrobial treatment for nosocomial infections based on a French prevalence survey. J Hosp Infect 1999; 42: 303-12.
8. Martin C, Pourriat J.-L. Quality of perioperative antibiotic administration by french anaesthesist. J Hosp Infect 1998; 40: 47-53.
9. Bertrand X, Thouverez M. Talon D et al. Endemicity, molecular diversity and colonisation routes of Pseudomonas aeruginosa in intensive care units. Intensive Care Med 2001; 27: 1263-8.
10. Blanc DS, Petignat C, Janin 8, Bille J, Francioli P. Frequency and molecular diversity of Pseudomonas aeruginosa upon admission and during hospitalization: A prospective epidemiologic study. Clinical Microbiology Infect 1998; 4: 242-7.
11. Fluit AC, Wielders CL, Verhoef J, Schmitz FJ. Epidemiology and susceptibility of 3,051 Staphylococcus aureus isolates from 25 university hospitals participating in the European SENTRY study. J Clin Microbiol 2001; 39: 3727-32.
12. Suntharam N, Hacek D, Peterson LR. Low prevalence of community-acquired methicillin-resistant Staphylococcus aureus in adults at a university hospital in the central United States. J Clin Microbiol 2001; 39: 1669-71.
13. Chambers HF. The changing epidemiology of Staphylococcus aureus ? Emerg infect Dis 2001; 7: 178-82.
14. Lallemand S, Albin C, Huc B et al. L'antibioprophylaxie en chirurgie. Conformité des prescriptions en Franche-Comté par rapport au referentiel national. Ann Chir 2001, 126: 463-71.